Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-22T16:13:15.820Z Has data issue: false hasContentIssue false
  • English
  • Français

Platelet monoamine oxidase in attempted suicide. Relations to sex, psychiatric diagnosis, mode of attempt, and previous attempts

Published online by Cambridge University Press:  16 April 2020

J Tripodianakis ,
M Markianos ,
D Sarantidis ,
C Istikoglou ,
A Andara  and
E Bistolaki
J Tripodianakis
Affiliation:
Psychiatric Department, Evangelismos General Hospital Athens University Medical School, Psychiatric Clinic, Eginition Hospital, Athens, Greece
M Markianos
Affiliation:
Athens University Medical School, Psychiatric Clinic, Eginition Hospital, Athens, Greece
D Sarantidis
Affiliation:
Psychiatric Department, Evangelismos General Hospital Athens University Medical School, Psychiatric Clinic, Eginition Hospital, Athens, Greece
C Istikoglou
Affiliation:
Psychiatric Department, Evangelismos General Hospital Athens University Medical School, Psychiatric Clinic, Eginition Hospital, Athens, Greece
A Andara
Affiliation:
Psychiatric Department, Evangelismos General Hospital Athens University Medical School, Psychiatric Clinic, Eginition Hospital, Athens, Greece
E Bistolaki
Affiliation:
Athens University Medical School, Psychiatric Clinic, Eginition Hospital, Athens, Greece
Get access

Summary

Platelet monoamine oxidase (MAO) activities were assessed in 82 patients, 57 females and 25 males, who were admitted to the medical ward of a general hospital after a suicide attempt. The enzyme activities were compared to the activities of healthy subjects, 35 females and 26 males. In addition, MAO activities were analyzed in relation to sex, psychiatric diagnosis, mode of attempt, drugs ingested, and previous attempts. Compared to normal controls, only female patients showed lower MAO activities. In the male population, lower activities were found in the subgroup of patients who had made previous attempts. In relation to diagnosis, analysis performed in the female population revealed lower MAO activities in the dysthymic and personality disorder, and not in the adjustment or major affective disorder subgroups. MAO activities were not related to the violent mode of attempt, the type of medication used, or the score in the Beck Suicidal Intent scale. The finding of low platelet MAO activities in dysthymic disorder, indicates the need for further studies of biological variables in this underdiagnosed and undertreated diagnostic group.

Keywords

attempted suicideplatelet MAOpsychiatric diagnosisdysthymic disorderpersonality disorder
Type
Original Articles
Information
European Psychiatry , Volume 10 , Issue 1 , 1995 , pp. 44 - 48
Copyright
Copyright © Elsevier, Paris 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Agren, HLife at risk: markers of suicidality in depression. Psychiatr Dev. 1983;1: 87–103Google ScholarPubMed
Beck, ATBeck, RKovacs, MClassification of suicidal behaviors. I. Quantifying intent and medical lethality. Am J Psychiatry. 1975;132: 285–7Google ScholarPubMed
Belmaker, RHBracha, HSEbstein, RPPlatelet monoamine oxidase in affective illness and alcoholism. Schizophr Bull. 1980;6: 320–310.1093/schbul/6.2.320CrossRefGoogle ScholarPubMed
Buchsbaum, MSCoursey, RDMurphy, DLThe biochemical high risk paradigm: behavioral and familial correlates of low platelet monoamine oxidase activity. Science. 1976;194: 339–4110.1126/science.968488CrossRefGoogle ScholarPubMed
Eckert, BGottfries, C-Gvon, Knorring LOreland, LWiberg, AWinblad, BBrain and platelet monoamine oxidase in mental disorders. I. Schizophrenics and cycloid psychotics. Prog Neuropsychopharmacol Biol Psychiatry. 1980;4:57–68Google ScholarPubMed
Fowler, CJOreland, LCallingham, BAThe acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J-508: their properties and applications. J Pharm Pharmacol. 1981;33: 341–710.1111/j.2042-7158.1981.tb13800.xCrossRefGoogle ScholarPubMed
Fowler, CJTipton, KFMcKay, AVPYoudim, MBHHuman platelet monoamine oxidase. A useful enzyme in the study of psychiatric disorders?. Neuroscience. 1982;7: 1577–9410.1016/0306-4522(82)90016-1CrossRefGoogle Scholar
Kocsis, JHMarkowitz, JCPrien, RFComorbidity of dysthymic disorder. In: Maser, JDCloninger, CRComorbidity in Anxiety and Mood Disorders. Washington DC: American Psychiatric Press, 1990 317–28Google Scholar
Lykouras, EMoussas, GMarkianos, MPlatelet monoamine oxidase and plasma dopamine beta hydroxylase activities in nonabstinent chronic alcoholics. Relations to clinical parameters. Drug Alcohol Depend. 1987;19: 363–8CrossRefGoogle Scholar
Markowitz, JCMoran, MEKocsis, JHFrances, AIPrevalence and comorbidity of dysthymic disorder among psychiatric outpatients. J Affective Dis. 1992;24: 63–71CrossRefGoogle ScholarPubMed
Meltzer, HYArora, RCPlatelet markers of suicidality. Ann NY Acad Sci USA. 1986;487: 271–8010.1111/j.1749-6632.1986.tb27906.xCrossRefGoogle ScholarPubMed
Murphy, DLWright, CBuchsbaum, MSNichols, ACosta, JLWyatt, RJPlatelet and plasma amine oxidase activity in 680 normals: sex and age differences and stability over time. Biochem Med. 1976;16: 254–65CrossRefGoogle Scholar
Nies, ARobinson, DSLamborn, KRLampert, RPGenetic control of platelet and plasma monoamine oxidase activity. Arch Gen Psychiatry. 1973;28: 834–810.1001/archpsyc.1973.01750360060008CrossRefGoogle ScholarPubMed
Perris, CEisemann, Mvon, Knorring LOreland, LPerris, HPersonality traits and monoamine oxidase activity in platelets in depressed patients. Neuropsychobiology. 1984;12: 201–5Google ScholarPubMed
Schalling, DAsberg, MEdman, GOreland, LMarkers for vulnerability to psychopathology: temperament traits associated with platelet MAO acticity. Acta Psychiatr Scand. 1987;76: 172–8210.1111/j.1600-0447.1987.tb02881.xCrossRefGoogle Scholar
Stahl, SMThe human platelet. A diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders. Arch Gen Psychiatry. 1977;34: 509–16CrossRefGoogle Scholar
von, Knorring LOreland, LWinblad, BPersonality traits related to monoamine oxidase activity in platelets. Psychiatry Res. 1984;12: 11–26Google Scholar
von, Knorring ALHallman, Jvon, Knorring LOreland, LPlatelet monoamine oxidase activity in type 1 and type 2 alcoholism. Alcohol Alcoholism. 1991;26: 409–16Google Scholar
Weissman, MMLeaf, PILivingston, MFlorio, LThe epidemiology of dysthymia in five communities: rates, risks, comorbidity, and treatment. Am J Psychiatry. 1988;145: 815–9Google ScholarPubMed
Wyatt, RJMurphy, DLBelmaker, RCohen, SDonnelly, CHPollin, WReduced monoamine oxidase activity in platelets: a possible genetic marker for vulnerability to schizophrenias. Science. 1973;179: 916–810.1126/science.179.4076.916CrossRefGoogle Scholar
Wyatt, RJPotkin, SJBridge, TPPhelps, BHWise, CDMonoamine oxidase in schizophrenia: an overview. Schizophr Bull. 1980;6: 199–207CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.